Patents Assigned to OPTIPHARM CO., LTD.
  • Publication number: 20170211156
    Abstract: There are provided an information offering method for diagnosing breast cancer comprising: (a) separating total RNA from a cell obtained from a tissue or blood of a suspected cancer patient; (b) synthesizing a cDNA from the separated total RNA; (c) performing a real-time PCR with the synthesized cDNA by using primer pair mix and probe mix that can amplify human epidermal growth factor receptor 2 (HER2); wherein, the primer pair mix that can amplify human epidermal growth factor receptor 2 (HER2) are described as SEQ ID Nos.:1 and 2, 3 and 4, and 6 and 7 and the probe mix are described as SEQ ID Nos.: 5, 8, and 9.
    Type: Application
    Filed: March 9, 2017
    Publication date: July 27, 2017
    Applicants: Optipharm Co., Ltd., University Industry Foundation, Yonsei University Wonju Campus
    Inventors: Hye Young Lee, Seung Il Kim, Hye Young Wang, Sang Jung Park
  • Patent number: 9469842
    Abstract: The present invention relates to a Korean-type porcine reproductive and respiratory syndrome virus (PRRSV) and a vaccine composition using the same, and a method for preventing porcine reproductive and respiratory syndrome. Korean-type porcine reproductive and respiratory syndrome virus with accession number KCTC 12096BP according to the present invention is Korean-type porcine reproductive and respiratory syndrome virus distinguished from European strains and North American strains, and a vaccine composition specific to Korean-type porcine reproductive and respiratory syndrome virus is produced, thereby preventing a Korean-type porcine reproductive and respiratory syndrome virus or specifically diagnosing the infection with Korean-type porcine reproductive and respiratory syndrome virus.
    Type: Grant
    Filed: February 3, 2014
    Date of Patent: October 18, 2016
    Assignee: OPTIPHARM CO., LTD.
    Inventors: Hyun Il Kim, Seong Ho Shin, Beom Ku Han